FreeOx
FreeOx Biotech develops medicines to reduce the effects of oxidative stress in the organism.
FreeOx has raised €2.2M across 2 funding rounds from 2 investors, most recently a Seed round in Dec 2023. Based in Barcelona, Spain; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.2M
€2,200,000
Funding rounds
2
Investors
2
distinct backers
Active since
2018-11
latest 2023-12
Funding by year
EUR raised per yearFreeOx — funding by year — interactive chart.
Data table
| FreeOx — funding by year | |
|---|---|
| 2018 | €500k |
| 2023 | €1.7M |
Signals
Medium confidenceRaise-next likelihood10
base rate 44% for Seed
- ▼ Past typical raise window
- ▲ Up-round momentum
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-12-06 | Seed | €1.7M | — | View deal → |
| 2018-11-08 | Seed | €500k | Javier Alsina,Montserrat Esteve | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData